ID Name Structure References (top 5) Molecular Target(s)
1ID:169
AJMALINE


NSC#:15627
NSC#:72132
NSC#:628054
Aldrich#:A7252

Freqency:
in 1 ingredients:

  • 937

  • Properties
    C20H26N2O2    326.44





    1:  Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P.
    Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts.
    Circulation.    impact factor:   9.903
    2000;  101(5): 510-5

    2:  Dhein S, Muller A, Gerwin R, Klaus W.
    Comparative study on the proarrhythmic effects of some antiarrhythmic agents.
    Circulation.    impact factor:   9.903
    1993;  87(2): 617-30

    3:  Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR.
    The Brugada syndrome: clinical, electrophysiologic and genetic aspects.
    J Am Coll Cardiol.    impact factor:   7.368
    1999;  33(1): 5-15

    4:  Chiale PA, Sanchez RA, Franco DA, Elizari MV, Rosenbaum MB.
    Overdrive prolongation of refractoriness and fatigue in the early stages of human bundle branch disease.
    J Am Coll Cardiol.    impact factor:   7.368
    1994;  23(3): 724-32

    5:  Stys PK.
    Protective effects of antiarrhythmic agents against anoxic injury in CNS white matter.
    J Cereb Blood Flow Metab.    impact factor:   5.714
    1995;  15(3): 425-32

    BAD
    C-AMP
    CB-1
    CSK
    DDR
    MRP
    MDR1
    MRP
    P450
    SAP
    STEP
     
    Time used: 188 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005